Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA), sponsored by Sarissa Capital Management — the healthcare-focused activist investment firm led by Alex Denner — filed a Form 15-12G with the SEC on November 10, 2022, terminating its public registration and concluding the blank-check vehicle's lifecycle without a completed business combination. The SPAC went public in 2021 with a mandate to pursue acquisition opportunities in the healthcare and biopharmaceutical sector. The deregistration places SRSA among the large cohort of pandemic-era SPACs that wound down as deal activity slowed sharply in the back half of 2022. Sign up at SpacDesk for the full filing history, sponsor profile, and deal timeline on SRSA.